Date: Tuesday, June 5, 2018
Session Time: 6:00pm-7:00pm
Presentation Time: 6:00pm-7:00pm
Location: Hall 4EF
KTx from DD with AKI can be a good source of kidneys however these kidneys are underutilized. The aim of this study is to determine the outcomes after KTx from DD with AKIN stage 2 and 3 AKI.
We included KTx from DD at our center between 2008 and 9/2017. We discard kidneys with more than 10% cortical necrosis or more than mild chronic changes on pre-implantation biopsy. We extracted data from DonorNet in order to classify the severity of AKI using the AKIN staging system (stage 0-3). The primary outcome is graft survival including death for AKIN 2-3 compared to AKIN 0-1.
We were able to determine the AKIN stage in 1193 (83.7%) of the DD KTx during this period. 593 (49.7%) were AKIN stage 2-3. The AKIN 2-3 group was more likely diabetic and on dialysis pre KTx. AKIN 2-3 group donors were younger (38.1 (14.8) vs. 42.7 (18.9), p<.01) more likely male and black race and had lower KDPI (51.8 (24.0) vs. 55.9 (27.9),p=0.01). DGF was more common in the AKIN 2-3 group (67.1% vs. 32.0%, p<.0001). Median (IQR) years follow up was 2.8 (1.4-4.5) in the AKIN 2-3 group and 3.9 (1.5-6.1) in the AKIN 0-1 group. Even after controlling for the baseline differences, graft survival was better in the AKIN 2-3 group (HR 0.67, 95% CI 0.49-91-0.94). The eGFR at 1 year was higher in the AKIN 2-3 group.
|AKIN 0-1||AKIN 2-3||P|
|eGFR 1 year [mean (SD)]||55.0( 20.9)||59.0( 21.3)||<0.01|
|Acturial 3 year graft survival ( %)||83.8||90.1||0.02|
|Number at risk at 3 years||369||274|
Reperfusion biopsies (RBx) were available in 65.8% of the AKIN 2-3 group and 62.3% in the AKIN 0-1 group. There were less chronic changes in the AKIN 2-3 group (e.g., %ci> 0: 17.3 vs. 34.2, p=0.02).
KTx from DD with AKIN stage 2-3 is associated with excellent graft survival and GFR. RBx showed less chronic changes in the AKIN 2-3 group. These findings suggest that our selection process for accepting DD with severe AKI is effective. More study of the value of pre-implantation biopsy in the selection process for AKI kidneys is necessary.
CITATION INFORMATION: Kumar A., Reddy K., Srinivasan A., Huskey J., Khamash H., Smith M., Moss A., Heilman R. Kidney Transplantation (KTx) Using Kidneys from Deceased Donors (DD) with AKIN Stage 2 and 3 Are Associated with Excellent Graft Outcomes Am J Transplant. 2017;17 (suppl 3).
To cite this abstract in AMA style:Kumar A, Reddy K, Srinivasan A, Huskey J, Khamash H, Smith M, Moss A, Heilman R. Kidney Transplantation (KTx) Using Kidneys from Deceased Donors (DD) with AKIN Stage 2 and 3 Are Associated with Excellent Graft Outcomes [abstract]. https://atcmeetingabstracts.com/abstract/kidney-transplantation-ktx-using-kidneys-from-deceased-donors-dd-with-akin-stage-2-and-3-are-associated-with-excellent-graft-outcomes/. Accessed January 21, 2020.
« Back to 2018 American Transplant Congress